Skip to main content

Proceeding contribution from Ann Keen (Labour) in the House of Commons on Wednesday, 20 May 2009. It occurred during Adjournment debate on Clatterbridge Centre for Oncology.


Clatterbridge Centre for Oncology

I accept my hon. Friend's reluctance to accept my argument during this debate. I feel confident that the argument will continue outside the Chamber. I ask him to look at the figures and to accept that the link with the university of Liverpool and its Cancer Research UK centre is, as I am sure he will agree, an enormously valuable possibility. I am aware that Cheshire and Merseyside primary care trusts, with support from the cancer network, are in the process of developing a specification for the additional radiotherapy units. I have been informed that the latest position is that Cheshire and Merseyside PCTs will consider the proposal of additional radiotherapy provision north of the Mersey at Aintree and the Royal at their next round of board meetings in June of this year. It is important to note that this review, when fully implemented, will lead to a substantial investment in non-surgical oncology, as some £30 million is being invested to bring new radiotherapy treatment facilities north of the Mersey. However, it is equally important that services are improved for Wirral and western Cheshire patients at the Clatterbridge Centre for Oncology. It is crucial that any improvement builds on the current excellent performance and services offered to all patients by this specialist cancer trust, which was scored excellent for both quality of services and use of resources by the Healthcare Commission in 2007-08. I am assured that the proposal to tender the radiotherapy service at the Royal Liverpool hospital will be in line with national competition policy and NHS cancer commissioning guidance. I am informed that although the detail is yet to be concluded, it is likely that potential providers will be invited to put forward proposals that identify how they would source capital and what implications that would have for unit costs and tariff. Clearly, the tendering process will be a "commercial in confidence" exercise, and it would be inappropriate for me to comment further. However, I hope that the Clatterbridge centre will be able to tender for that additional capacity in due course. I am confident that my hon. Friend will continue to champion and support health services and, in particular, cancer services in his constituency—as will all those who have spoken in tonight's debate—and I encourage him to engage with the local organisations throughout the planning stages. The past 10 years have witnessed real progress in cancer services nationally. I hope that the proposals that he has brought to our attention today will make a real and tangible difference to the people of Merseyside. I know that the prevention of inequalities and the work that has to take place to reduce those figures and that worrying trend are also part of our work as Members of Parliament and as Ministers. I want to express my best wishes to all those involved in the process of achieving those aims. Question put and agreed to.


Secondary information

Type
Proceeding contribution
Reference
492 c1614-6 
Session
2008-09
Chamber / Committee
House of Commons chamber
Subjects
Consultants Diseases NHS Medical treatments Research Clatterbridge Centre for Oncology NHS Foundation Trust Clatterbridge Centre for Oncology
Link
View this Proceeding contribution on www.publications.parliament.uk